Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TW-37 |
Trade Name | |
Synonyms | |
Drug Descriptions |
TW-37 is a third-generation BH3 mimetic that inhibits BCL2, MCL1, and with lesser affinity, BCL-XL, which may result in increased tumor cell apoptosis and increased sensitivity to chemotherapeutics (PMID: 17404107, PMID: 32257914). |
DrugClasses | BCL-XL inhibitor 14 BCL2 inhibitor 27 MCL1 Inhibitor 18 |
CAS Registry Number | 877877-35-5 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Trametinib + TW-37 | TW-37 Trametinib | 2 | 0 |
TW-37 | TW-37 | 0 | 0 |
TW-37 + Vemurafenib | TW-37 Vemurafenib | 2 | 0 |